Seeing Is Believing
Currently out of the existing stock ratings of Caroline Palomeque, 4 are a BUY (100%).
Analyst Caroline Palomeque works with a stock forecast success ratio of 25% fulfilled within 452 days on average.
Caroline Palomeque’s has documented 7 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AVXL, Anavex Life Sciences Corp at 23-Jun-2022.
Analyst best performing recommendations are on AVXL (ANAVEX LIFE SCIENCES CORP).
The best stock recommendation documented was for AVXL (ANAVEX LIFE SCIENCES CORP) at 5/16/2018. The price target of $7 was fulfilled within 904 days with a profit of $4.56 (186.89%) receiving and performance score of 2.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
3 months 20 days ago
4/8 (50%)
$38.89 (350.05%)
155
Buy
28
$24.32 (660.87%)
35
1 years 2 months 15 days ago
0/2 (0%)
$17.59 (168.97%)
Hold
11
$7.32 (198.91%)
16
1 years 4 months 18 days ago
4/7 (57.14%)
$2.62 (31.26%)
134
Buy
40
$36.32 (986.96%)
7
1 years 10 months 1 days ago
1/2 (50%)
$29.55 (282.78%)
904
Buy
35
$31.32 (851.09%)
19
2 years 10 months 3 days ago
6/7 (85.71%)
$9.83 (39.05%)
1278
What Year was the first public recommendation made by Caroline Palomeque?